Clinical Trial Update: Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing whether incretin affects blood pressure and lipid profiles in overweight or obese patients with Type 2 Diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Masked Hypertension
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Incretin (incretin-based therapy)

Snippet

Sponsor: Third Affiliated Hospital of Third Military Medical University | Conditions: Type 2 Diabetes, Overweight | Phase 4 | Status: UNKNOWN